We have observed
1 EP application
Per Hampus Rystedt
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 14, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER